Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
47,3 ILa | -1,87% | -9,39% | +19,14% |
Vakgebied
Verkoop per activiteit
ILS in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100,0
%
| 132 | 100,0 % | 18 | 100,0 % | -86,35% |
Verkoop per regio
ILS in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 132 | 100,0 % | 18 | 100,0 % | -86,35% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 01-07-15 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-01-22 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | 70 | 15-05-07 | |
Iris Sadeh
AUD | Comptroller/Controller/Auditor | - | 01-01-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 67 | 09-05-03 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 18-11-15 |
Gad Keren
BRD | Director/Board Member | 73 | 17-02-20 |
Gabriel Barbash
BRD | Director/Board Member | 74 | 25-03-03 |
Director/Board Member | 39 | 05-12-17 | |
Nufar Malovani
BRD | Director/Board Member | 46 | 19-11-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 161 256 549 | 55 870 242 ( 34,65 %) | 4 410 349 ( 2,735 %) | 34,65 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
GAMIDA CELL LTD. 1.68% | 2 581 746 | 1.68% | 46 471 $ |
Bedrijfsgegevens
Clal Biotechnology Industries Ltd.
Triangle Building Azrieli Center 3
67023, Tel Aviv
+
http://www.cbi.co.ilSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,14% | 20,37 mln. | |
+22,25% | 79,06 mld. | |
+73,34% | 19,27 mld. | |
+13,88% | 17,55 mld. | |
+13,04% | 14,66 mld. | |
+5,89% | 13,25 mld. | |
+4,92% | 11,83 mld. | |
+7,46% | 11,01 mld. | |
+36,89% | 10,55 mld. | |
+0,39% | 10,04 mld. |